These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 37298089)

  • 21. A Novel Time-Resolved Fluorescence Resonance Energy Transfer Assay for the Discovery of Small-Molecule Inhibitors of HIV-1 Tat-Regulated Transcription.
    Shin YH; Kim DE; Yu KL; Park CM; Kim HG; Kim KC; Bae S; Yoon CH
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication.
    Hwang S; Tamilarasu N; Kibler K; Cao H; Ali A; Ping YH; Jeang KT; Rana TM
    J Biol Chem; 2003 Oct; 278(40):39092-103. PubMed ID: 12857725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
    Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
    PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HIV-1 Integrase C-Terminal Domain Induces TAR RNA Structural Changes Promoting Tat Binding.
    Rocchi C; Louvat C; Miele AE; Batisse J; Guillon C; Ballut L; Lener D; Negroni M; Ruff M; Gouet P; Fiorini F
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory.
    Beck H; Härter M; Haß B; Schmeck C; Baerfacker L
    Drug Discov Today; 2022 Jun; 27(6):1560-1574. PubMed ID: 35202802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition.
    Alanazi A; Ivanov A; Kumari N; Lin X; Wang S; Kovalskyy D; Nekhai S
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAR RNA Mediated Folding of a Single-Arginine-Mutant HIV-1 Tat Protein within HeLa Cells Experiencing Intracellular Crowding.
    Kim JM; Chun H
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein.
    Sosic A; Olivato G; Carraro C; Göttlich R; Fabris D; Gatto B
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33810333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of Novel Protein Interaction Assays between Sin3 and REST Using Surface Plasmon Resonance and Time-Resolved Fluorescence Energy Transfer.
    Harada M; Nagai J; Kurata R; Cui X; Isagawa T; Semba H; Yoshida Y; Takeda N; Maemura K; Yonezawa T
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depicting HIV-1 Transcriptional Mechanisms: A Summary of What We Know.
    Dutilleul A; Rodari A; Van Lint C
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33287435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Aristolactam Derivatives That Act as Inhibitors of Human Immunodeficiency Virus Type 1 Infection and Replication by Targeting Tat-Mediated Viral Transcription.
    Shin Y; Park CM; Kim HG; Kim DE; Choi MS; Kim JA; Choi BS; Yoon CH
    Virol Sin; 2021 Apr; 36(2):254-263. PubMed ID: 32779073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-TEFb as A Promising Therapeutic Target.
    Fujinaga K
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32075058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel compounds against Tat-mediated human immunodeficiency virus-1 transcription by high-throughput functional screening assay.
    Shin Y; Kim HG; Park CM; Choi MS; Kim DE; Choi BS; Kim K; Yoon CH
    Biochem Biophys Res Commun; 2020 Mar; 523(2):368-374. PubMed ID: 31866007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
    Chavali SS; Bonn-Breach R; Wedekind JE
    J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A General TR-FRET Assay Platform for High-Throughput Screening and Characterizing Inhibitors of Methyl-Lysine Reader Proteins.
    Rectenwald JM; Hardy PB; Norris-Drouin JL; Cholensky SH; James LI; Frye SV; Pearce KH
    SLAS Discov; 2019 Jul; 24(6):693-700. PubMed ID: 31017815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex.
    Schulze-Gahmen U; Hurley JH
    Proc Natl Acad Sci U S A; 2018 Dec; 115(51):12973-12978. PubMed ID: 30514815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a dual reporter screening assay for distinguishing the inhibition of HIV Tat-mediated transcription from off-target effects.
    Shin Y; Choi BS; Kim KC; Kang C; Kim K; Yoon CH
    J Virol Methods; 2017 Nov; 249():1-9. PubMed ID: 28807730
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.